In the validation set (GSE190496), we observed a significant increase in the gene expression levels of LSS, HYOU1, ACADVL, PRKAB2, PLIN2, AUP1, and DAP in the COVID-19 group compared to the control group (Figure 5A). The gene discussed is AUP1; the disease is COVID-19.